$0.06

-0.00 (-5.72%)

Weekly Expected Move ±16.7%

$0 $0 $0 $0 $0

OTC · Healthcare · Biotechnology · Tech Score Sell · Power 39 · $743245 mcap · 12M float · 0.769% daily turnover · Short 30% of daily vol

Revenue

$4M +0.0% ▲

Gross Profit

$3M +0.0% ▲

Operating Income

$81K +0.0% ▲

Net Income

-$6M +0.0% ▲

EPS (Diluted)

$-0.44 +0.0% ▲

EBITDA

$299K +0.0% ▲

View Full Income Statement

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1M	$984K	$1M	$2M	$3M	$4M
Cost of Revenue	$420K	$398K	$679K	$792K	$873K	$2M
Gross Profit	$944K	$586K	$502K	$779K	$2M	$2M
Gross Margin	69.2%	59.6%	42.5%	49.6%	66.9%	61.3%
R&D Expenses	$0	$0	$0	$0	$0	$0
SG&A Expenses	$735K	$719K	$824K	$950K	$1M	$2M
Operating Expenses	$735K	$836K	$947K	$1M	$2M	$2M
Operating Income	$135K	-$250K	-$446K	-$306K	$230K	$566K
Operating Margin	9.9%	-25.4%	-37.8%	-19.5%	8.7%	14.1%
Interest Expense	$894K	$1M	$3M	$2M	$2M	$2M
Income Before Tax	-$760K	-$1M	-$4M	-$1M	-$876K	-$3M
Tax Expense	$0	$0	$0	$0	$0	$0
Net Income	-$760K	-$1M	-$4M	-$1M	-$876K	-$3M
Net Margin	-55.7%	-132.8%	-368.8%	-88.6%	-33.2%	-72.2%
EPS (Diluted)	$-0.06	$-0.10	$-0.35	$-0.11	$-0.07	$-0.22
EBITDA	$186K	-$196K	-$787K	$713K	$1M	$657K
Shares Outstanding	13M	13M	13M	13M	13M	13M

RMTG OTC